Skip to main content

Table 5 Surgical outcomes among patients undergoing radical cystectomy by antidepressant use before cancer diagnosis

From: Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

Surgical outcome

Non-users

AD users

Length of stay (LOS)

 Days admitted, median (IQR)

10 (7–13)

9 (8–13)

 Unadjusted ratio of median LOS (95% CI)

Ref.

1.03 (0.95–1.13)

 Adjusteda ratio of median LOS (95% CI)

Ref.

1.02 (0.93–1.12)

30-day acute readmission

 Total, n

2241

151

 Readmitted, n

747

62

 Cumulative incidence, % (95% CI)

33.4 (31.4–35.3)

41.1 (33.2–48.8)

 Unadjusted HR (95% CI)

Ref.

1.36 (1.08–1.71)

 Adjusteda HR (95% CI)

Ref.

1.33 (1.05–1.67)

90-day postoperative procedure

 Total, n

2370

162

 Procedures, n

908

72

 Cumulative incidence, % (95% CI)

38.3 (36.4–40.3)

44.4 (36.7–51.9)

 Unadjusted HR (95% CI)

Ref.

1.19 (0.93–1.51)

 Adjusted* HR (95% CI)

Ref.

1.18 (0.93–1.51)

One-year all-cause mortality

 Total, n

2370

162

 Deaths, n

330

24

 Cumulative incidence, % (95% CI)

14.4 (13.1–16.0)

15.0 (10.3–21.6)

 Unadjusted HR (95% CI)

Ref.

1.05 (0.69–1.58)

 Adjusteda HR (95% CI)

Ref.

0.96 (0.63–1.46)

Three-year all-cause mortality

  

 Total, n

2370

162

 Deaths, n

650

52

 Cumulative incidence, % (95% CI)

31.3 (29.3–33.4)

35.4 (28.1–43.8)

 Unadjusted HR (95% CI)

Ref.

1.16 (0.88–1.54)

 Adjusteda HR (95% CI)

Ref.

1.02 (0.77–1.36)

  1. The analysis of acute readmission excludes patients with a primary admission longer than 30 days (n = 140). AD antidepressant, IQR interquartile range, CI confidence interval, HR hazard ratio. aAdjusted for age, sex, CCI, alcohol-related disorders, and marital status